Pharmaco - Press Releases

Date	Title	Company
28-Jan-2021	Douglas’ sales almost stable at over €3 bn despite COVID-19 and due to strong e-commerce growth	Douglas GmbH
28-Jan-2021	Douglas GmbH: Douglas reduces its store network by around 500 stores; ongoing EBITDA contribution of around 120 million euros and net one-off cash charge of 94 million euros expected	Douglas GmbH
28-Jan-2021	MeVis Medical Solutions AG: MeVis publishes figures for fiscal year 2019/2020 and forecast for 2020/2021	MeVis Medical Solutions AG
28-Jan-2021	Evotec Starts Clinical Development of Chikungunya Antibody together with NIAID and Leading Academic Research Organisation	Evotec SE
28-Jan-2021	PAION AG: ACACIA PHARMA LAUNCHES BYFAVO(TM) (REMIMAZOLAM) IN THE U.S. FOR PROCEDURAL SEDATION IN ADULTS UNDERGOING MEDICAL PROCEDURES LASTING 30 MINUTES OR LESS	PAION AG
28-Jan-2021	Key figures for 2020 financial year – Sales and EBIT exceed expectations communicated in December	COLTENE Holding AG
27-Jan-2021	Epigenomics AG successfully places mandatory convertible bond in the full amount of EUR 5.5 million	Epigenomics AG
27-Jan-2021	eNUVIO is Launching the OMEGA-96 Device	eNUVIO
27-Jan-2021	BenevolentAI today announced that the biopharmaceutical company AstraZeneca has selected a novel chronic kidney disease (CKD) target to advance to its drug development portfolio, making it the first AI-generated target from the collaboration to enter the Company’s portfolio.	BenevolentAI and AstraZeneca
27-Jan-2021	Polyplus-transfection initiates construction of Vectura, a new 4,000m2 facility	Polyplus-transfection® SA
27-Jan-2021	Insilico announces the release of the Insilico Selector for accurate selection of high-performing cell clones using micro-scale data	Insilico
27-Jan-2021	European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease	Global Blood Therapeutics, Inc.
27-Jan-2021	ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital	ADVANZ PHARMA
27-Jan-2021	Orexo strengthens IP rights for overdose rescue drug OX124	Orexo AB
27-Jan-2021	Endogena completes $8 million financing and extends Series A round to advance its novel treatments for neurodegenerative diseases	Endogena
27-Jan-2021	Certa Sine pump makes transporting high-viscosity 3D printing materials easy	Sciad Newswire
27-Jan-2021	Epigenomics AG: Dr. Garces transitions to Company Advisor	Epigenomics AG
27-Jan-2021	Just - Evotec Biologics Expands Contract with the Department of Defense for Manufacturing of Monoclonal Antibodies	Evotec SE
27-Jan-2021	Rapid Nutrition PLC: Rapid Nutrition attracts USD 1 million investment with Swiss company Nice & Green to fund its growth strategy	Rapid Nutrition PLC
26-Jan-2021	Siemens Healthineers AG: Q1 results significantly better than market expectations; Outlook for FY2021 raised	Siemens Healthineers AG